In this educational program, the role of novel diabetes treatment approaches in the prevention of CVD in patients with T2DM is discussed in three parts.

This course consists of 3 lectures:

• The cardiology challenge to manage diabetes in cardiovascular risk reduction - Nikolaus Marx, MD - Aachen, Germany
• Cardiovascular outcomes & atherosclerosis: How do GLP-1RA provide benefits? - Jorge Plutzky, MD - Boston, MA, USA
• Changing paradigm in prediabetes and CVD: Potential for new concepts and new tools - John E Deanfield, MD - London, United Kingdom

After watching three videos on the patient with diabetes and cardiovascular outcomes, the learner should be able to:

• Understand the relation between T2DM & Cardiovascular Disease
• Identify the needs for novel approaches targeting T2DM in cardiovascular prevention
• Explore results from recent cardiovascular outcome trials (CVOT) in T2DM
• Discuss potential mechanisms and multifactorial effects of GLP-1 receptor agonists contributing to cardiovascular benefits
• Discuss practical implications from recent CVOTs on treatment and prevention strategies in patients with CV risk and T2DM.

Expert faculty

• Nikolaus Marx, MD, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.
• Jorge Plutzky, MD, cardiologist in the Brigham and Women's Hospital and Associate Prof at the Harvard Medical School in Boston, MA, USA.
• John E. Deanfield, MD, Professor of Cardiology, University College London, United Kingdom.

Target audience

This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in treating diabetes patients with chronic kidney disease.

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.